Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 7/13/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Carlo Patrono

Wrong Dr. Carlo Patrono?

Professor and Chair of the Depart...

Email: c***@***.it
Local Address: Rome, Italy
Catholic University School of Medicine
 
Background

Employment History

Board Memberships and Affiliations

Education

  • M.D.
  • M.D. degree
    Catholic University
35 Total References
Web References
Carlo Patrono, ...
www.congressmed.com, 13 July 2014 [cached]
Carlo Patrono, Italy Department of Pharmacology at the Catholic University School of Medicine (UCSC)
EACPT Lifetime Achievement Awards ...
www.eacpt.org, 2 May 2013 [cached]
EACPT Lifetime Achievement Awards announced for Professor Sir Michael Rawlins and Professor Carlo Patrono
...
We are delighted to announce that the 2013 Lifetime Achievement Award of the European Association of Clinical Pharmacology and Therapeutics will go jointly to Professor Sir Michael Rawlins and to Professor Carlo Patrono, for their outstanding contributions to the national and international benefits of clinical pharmacology for medicine, health care and patient safety.
...
Carlo Patrono is Professor and Chair of the Department of Pharmacology at the Catholic University School of Medicine (UCSC) in Rome, Italy. He is also the Chairman of the Task Force on Antiplatelet Agents of the European Society of Cardiology.
Prof. Patrono's main research interest is in the study of platelet activation and inhibition in atherothrombosis. He pioneered development of radioimmunoassays for measuring prostanoid and isoprostane biosynthesis in health and disease. His research has characterized the human pharmacology of aspirin as an inhibitor of platelet COX-1 and provided the basis for the development of low-dose aspirin as an antithrombotic agent. During the past decade Prof. Patrono has contributed to characterizing the human pharmacology of COX-2 inhibitors and evaluating their cardiovascular effects in different clinical settings.
For development of low-dose aspirin for the prevention of cardiovascular disease, Professor Patrono was joint recipient with Garret FitzGerald in April 2013 from the Institut de France of the 500,000 euro 2013 Grand Prix Scientifique, the world's most prestigious prize for cardiovascular research.
Emedsecurities: Investment Banking
www.emedsecurities.com, 24 Jan 2004 [cached]
K. Frank Austen, M.D. | Bengt Samuelsson, M.D. | Sir John Vane, D.Sc., FRS | Nicolas G. Bazan, M.D., Ph.D. | Charles A. Dinarello, M.D. | Stephen M. Prescott, M.D. | Lanny J. Rosenwasser, M.D. | Daniel D. Von Hoff, M.D. | David K. Brophy, Ph.D. | Brad Barber, Ph.D. | Campbell R. Harvey, Ph.D. | Henry I. Miller, M.D. | David J. Crossen, Ph.D. | Marc J. Ostro, Ph.D. | Alex McPherson, M.D., Ph.D. | Ronald Meade | Antoine A. Noujaim, Ph.D. | Ariel Elia | Carlo Patrono, M.D. | Thierry Jean, Ph.D.
...
Carlo Patrono, M.D.Dr. Patrono is the Director of the Center of Excellence on Aging and Professor of Pharmacology at G. D'Annunzio University School of Medicine in Chieti, Italy.Dr. Patrono received his M.D. degree from the Catholic University in Rome and trained as a postdoctoral fellow in New York with the late Solomon Berson and Nobel laureate Rosalyn Yalow.
...
Dr. Patrono has pioneered the human pharmacology of selective cyclooxygenase inhibitors, including low-dose aspirin and the recently developed COX-2 inhibitors.He is currently the Chairman of the task Force on Antithrombotic Agents of the European Society of Cardiology and serves on the editorial board of Circulation.He has been elected to membership in prestigious societies, including the Association of American Physicians, the European Society of Cardiology and the Royal College of Physicians of Ireland.Dr. Patrono has received numerous awards, including the Alexander B. Gutman award from the Mount Sinai School of Medicine, the Distinguished Award in Neuroscience from the Louisiana State University and the 1998 International Aspirin award.
Delegate CV's | European Association for Clinical Pharmacology and Therapeutics
www.eacpt.org [cached]
Carlo Patrono, MD,
is Professor and Chair of the Department of Pharmacology at the Catholic University School of Medicine in Rome, Italy. Dr. Patrono trained as a postdoctoral fellow in New York with the late Solomon Berson and Nobel Laureate Rosalyn Yalow. His main research interest is in the study of platelet activation and inhibition in atherothrombosis. His research has characterized the human pharmacology of aspirin as an inhibitor of platelet cyclooxygenase activity and provided the basis for the development of low-dose aspirin as an antithrombotic agent.
He is the Chairman of the Task Force on Antiplatelet Agents of the European Society of Cardiology and serves on the editorial board of Circulation and of Arteriosclerosis, Thrombosis, and Vascular Biology. He has been elected to membership in prestigious societies, including the Association of American Physicians, the Royal College of Physicians, the Academia Europaea and the Accademia dei Lincei. Dr. Patrono has published 185 original research articles and 113 book chapters. His h-index is 70. He has received the Alexander B. Gutman award from the Mount Sinai School of Medicine, the Distinguished Award in Neuroscience from the Louisiana State University, the 1998 International Aspirin® Award from Bayer AG and the 2007 John Vane Award from the William Harvey Research Institute of the University of London.
Professor Carlo Patrono, ...
www.addictiontherapycenter.co.uk, 29 July 2013 [cached]
Professor Carlo Patrono, professor of pharmacology at the University of Rome, said the study was underpowered.
'The sample size would have to be about four times larger to achieve the intended power. Lack of statistical power does seem to be by far the most likely explanation for the null results of the AAA trial.'
Professor Patrono claimed a forthcoming analysis from the Oxford Clinical Research Trials Unit, including the AAA study result, suggested there still was a positive effect from aspirin when used in primary prevention.
Other People with the name "Patrono":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304